Generation of an isogenic human induced pluripotent stem cell line harbouring a CLDN11 mutation associated with hypomyelinating leukodystrophy

Read full text Summarise with VIRAT
Authors: Sophia C. Gjervan, Glen Lester Sequiera, Jia Feng, Oguz K. Ozgoren, Katherine Van Belois, Braden Kersey, Colin J. Ross, Ramon I. Klein Geltink, Sylvia Stöckler, Mahmoud A. Pouladi
Cited by: 0
References: 3

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Stoploss mutations in CLDN11 were first described as the cause of hypomyelinating leukodystrophy 22 (HLD22). Since then, a novel variant in CLDN11, namely NM_005602.5:c.564del; p.(Arg189ValfsTer31), has been identified in patients with hypomyelinating leukodystrophy resembling HLD22. To better characterize the functional significance of this novel variant and to study the mechanisms underlying CLDN11-related HLDs, isogenic human induced pluripotent stem cell lines carrying the c.564del variant were generated on a PGP1 cell line background.

Fields of Study & Subjects

Pluripotent Stem Cells Research Multiple Sclerosis Research Studies Barrier Structure and Function Studies

Publication details

Journal / source
Stem Cell Research
Volume
93
Pages
103976–103976
Publication date
28 March 2026
Language
EN